RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
Home > Products
| Cat.No. | Product name | Product Description |
| R2032908 | NCB-0846 | NCB-0846 is an orally available TNIK inhibitor with an IC50 of 21 nM. |
| R2032909 | Sapacitabine | Sapacitabine is an orally available nucleoside analog prodrug that is structural |
| R2032910 | STAT5 | STAT5-IN-1 is a STAT5 inhibitor with an IC50 of 47 μM for STAT5β isoform. |
| R2032911 | TM5441 | TM5441 is an orally bioavailable inhibitor of plasminogen activator inhibitor-1 |
| R2032912 | A-1331852 | A-1331852 is an orally available BCL-XL selective inhibitor with a Ki of less th |
| R2032913 | AMG-3969 | AMG-3969 is a potent glucokinase-glucokinase regulatory protein interaction (GK- |
| R2032914 | Belizatinib(TSR011) | Belizatinib is an oral, dual, potent inhibitor of ALK and TRKA, TRKB, and TRKC, |
| R2032915 | BI605906 | BI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at |
| R2032916 | BMS378806 | BMS-378806 is a potent HIV-1 attachment inhibitor that interferes with CD4-gp120 |
| R2032917 | BMS-986020 | BMS-986020 is a high-affinity and selective lysophosphatidic acid receptor 1 (LP |
| R2032918 | Cenerimod(ACT-334441) | Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate |
| R2032919 | CZC25146 | CZC-25146 is a potent, selective and metabolically stable LRRK2 inhibitor with I |
| R2032920 | ETP-46321 | ETP-46321 is a potent and orally bioavailable PI3Kα and PI3Kδ inhibitor with Kia |
| R2032921 | JPH203 | JPH203 is a potent and selective L-type amino acid transporter 1 (LAT-1) inhibit |
| R2032922 | Q203 | Q203 (IAP6) is a midazopyridine amide compound.Q203 is active against Mycobacter |
| R2032923 | RAF709 | RAF709 is a potent, selective, and efficacious RAF inhibitor with IC50s of 0.4 n |
| R2032924 | RO6885247 | RG7800 is a SMN2 splicing modifier.RG7800 has the potential for spinal muscular |
| R2032925 | SUN11602 | SUN11602 is a novel aniline compound with basic fibroblast growth factor-like ac |
| R2032926 | UNC3866 | UNC3866 is a potent antagonist of the CBX7-H3 interaction as determined by Alpha |
| R2032927 | BMS309403 | BMS-309403 is a potent, selective and cell-permeable inhibitor of adipocyte fatt |
| R2032928 | CCT251236 | CCT251236 is an orally available pirin ligand from a heat shock transcription fa |
| R2032929 | CPI-268456 | CPI-268456 is a potential BET bromodomain inhibitor. |
| R2032930 | BRD-6125 | FPH1 (BRD-6125) is a small molecule, which promotes expansion of iPS-derived hep |
| R2032931 | Glesatinib hydrochloride | Glesatinib hydrochloride is an inhibitor of the MET and Axl receptor tyrosine ki |
| R2032932 | Ziritaxestat(GLPG1690) | Ziritaxestat (GLPG1690) is a first-in-class autotaxin (ATX) inhibitor, with an I |
